Prudential Financial
PRU NYSE Life & Health Insurance Financials FY2016βFY2025
Prudential Financial's revenue fell 13.7% to $60.8 billion in fiscal 2025. Its net margin was 5.9%, up from 3.9% a year earlier. It paid out $2.9 billion in dividends and buybacks. The diluted share count fell 1.6%.
About these figures. Prudential's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
What Prudential Financial does
No business description yet.
- Legal name
- PRUDENTIAL FINANCIAL INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001137774-26-000048
0001137774
Revenue and margins
Prudential Financial had $60.8B of revenue in fiscal 2025, down 13.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 0.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Prudential Financial returned $2.9B to shareholders in fiscal 2025. The diluted share count fell 1.6%.
Value Prudential Financial yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $856M and divides by 353.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 10.4x Β· peers 17.3x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Prudential Financial can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $19.5B | $21.8B | $19.4B | $18.5B | $19.7B |
| Debt incl. finance leases | $18.6B | $19.9B | $18.9B | $19.2B | $18.9B |
| Net debt / EBITDA | β0.1x | β | β | 0.1x | β0.1x |
| Debt / equity | 0.3x | β | β | β | β |
| Interest coverage | 8.3x | β0.2x | 2.7x | 2.6x | 3.4x |
| Total assets | $937.6B | $689.0B | $721.2B | $735.6B | $773.7B |
| Total liabilities | $875.0B | $657.1B | $691.3B | $705.5B | $738.2B |
| Shareholders' equity | $61.9B | $30.6B | $27.8B | $27.9B | $32.4B |
| Net debt (β = net cash) | β$901M | β$1.9B | β$537M | $690M | β$856M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
3 insiders
Sold, 12 months
$9.2M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Ann M KapplerEVP and General Counsel | Sold | 7,652 | $125.01 | $1.0M | Form 4 |
| May 14, 2026 | Ann M KapplerEVP and General Counsel | Sold | 13,580 | $103.25 | $1.4M | Form 4 |
| Feb 17, 2026 | Thomas D StoddardDirector | Bought | 250 | $102.97 | $0.0M | Form 4 |
| Feb 11, 2026 | Joseph J WolkDirector | Bought | 400 | $105.32 | $0.0M | Form 4 |
| Feb 6, 2026 | Jacques ChappuisExecutive Vice President | Bought | 1,000 | $100.97 | $0.1M | Form 4 |
| Dec 11, 2025 | Caroline FeeneyExecutive Vice President | Sold | 6,555 | $116.28 | $0.8M | Form 4 |
| Dec 2, 2025 | Timothy L SchmidtSenior Vice President | Sold | 8,000 | $107.69 | $0.9M | Form 4 |
| Nov 10, 2025 | Charles F LowreyChairman of the Board, Director | Sold | 48,164 | $107.39 | $5.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β0.6% | β0.8% | β0.4% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Prudential Financial PRU | $40.0B | β13.7% | β | β | β | 10.4x | β | |
| MetLife MET | $63.9B | 8.6% | 8.0% | β | β | 18.9x | β | Compare β |
| Aflac AFL | $60.9B | β9.3% | β | β | 13.0% | 13.0x | β | Compare β |
| Principal Financial Group PFG | $23.9B | β3.1% | β | β | β | 15.6x | β | Compare β |
| Unum UNM | $14.4B | 1.5% | β | 4.3% | 7.6% | 21.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $58.8B | $59.7B | $63.0B | $64.8B | $57.0B | $71.2B | $56.9B | $54.0B | $70.4B | $60.8B |
| Interest expense | $1.3B | $1.3B | $1.4B | $1.6B | $1.6B | $1.5B | $1.6B | $1.8B | $2.0B | $1.9B |
| Pretax income | $5.7B | $6.5B | $4.8B | $5.1B | β$323M | $10.8B | β$1.9B | $3.1B | $3.2B | $4.7B |
| Income tax | $1.3B | β$1.4B | $822M | $947M | β$81.0M | $2.0B | β$279M | $613M | $507M | $1.1B |
| Net income | $4.4B | $7.9B | $4.1B | $4.2B | β$374M | $8.9B | β$1.6B | $2.5B | $2.7B | $3.6B |
| Diluted EPS | $9.71 | $17.86 | $9.50 | $10.11 | β$1.00 | $22.40 | β$4.49 | $6.74 | $7.50 | $9.99 |
| Diluted shares | 0.45B | 0.44B | 0.43B | 0.41B | 0.40B | 0.39B | 0.37B | 0.36B | 0.36B | 0.35B |
| Cash flow | ||||||||||
| Cash from operations | $14.9B | $13.5B | $21.7B | $19.6B | $8.4B | $9.8B | $5.2B | $6.5B | $8.5B | $6.3B |
| Depreciation and amortization | $318M | $222M | $161M | $460M | $457M | $206M | $117M | β | $383M | $128M |
| Stock-based compensation | $202M | $263M | $155M | $231M | $226M | $268M | $208M | $254M | $314M | $257M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $2.0B | $1.3B | $1.5B | $2.5B | $500M | $2.5B | $1.5B | $1.0B | $1.0B | $1.0B |
| Dividends paid | $1.3B | $1.3B | $1.5B | $1.6B | $1.8B | $1.8B | $1.8B | $1.8B | $1.9B | $1.9B |
| Dividends and buybacks | $3.3B | $2.5B | $3.0B | $4.1B | $2.3B | $4.3B | $3.3B | $2.9B | $2.9B | $2.9B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $21.6B | $21.3B | $21.8B | $21.8B | $21.5B | $19.5B | $21.8B | $19.4B | $18.5B | $19.7B |
| Total debt | $18.0B | $17.2B | $17.4B | $18.6B | $19.7B | $18.6B | $19.9B | $18.9B | $19.2B | $18.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $784.0B | $832.1B | $815.1B | $896.6B | $940.7B | $937.6B | $689.0B | $721.2B | $735.6B | $773.7B |
| Total liabilities | $737.9B | $777.6B | $766.0B | $832.8B | $872.5B | $875.0B | $657.1B | $691.3B | $705.5B | $738.2B |
| Shareholders' equity | $45.9B | $54.2B | $48.6B | $63.1B | $67.4B | $61.9B | $30.6B | $27.8B | $27.9B | $32.4B |
| Margins | ||||||||||
| EBITDA margin | 12.5% | 13.5% | 10.2% | 11.0% | 3.0% | 17.6% | β0.3% | β | 8.0% | 11.0% |
| Net margin | 7.4% | 13.2% | 6.5% | 6.5% | β0.7% | 12.5% | β2.9% | 4.6% | 3.9% | 5.9% |
| Returns | ||||||||||
| Return on equity | 10.0% | 15.7% | 7.9% | 7.5% | β0.6% | 13.7% | β3.6% | β | β | β |
| Return on assets | 0.6% | 1.0% | 0.5% | 0.5% | β0.0% | 0.9% | β0.2% | 0.4% | 0.4% | 0.5% |
| Growth | ||||||||||
| Revenue growth | 2.9% | 1.6% | 5.5% | 2.9% | β12.0% | 24.9% | β20.2% | β5.1% | 30.4% | β13.7% |
| Net income growth | β22.6% | 80.0% | β48.2% | 2.8% | β108.9% | β | β118.6% | β | 9.6% | 31.1% |
| EPS growth | β20.2% | 83.9% | β46.8% | 6.4% | β109.9% | β | β120.0% | β | 11.3% | 33.2% |
| Share count change | β3.0% | β2.4% | β2.3% | β3.6% | β3.7% | β1.4% | β4.6% | β2.1% | β1.5% | β1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.5x | β0.5x | β0.7x | β0.4x | β1.1x | β0.1x | β | β | 0.1x | β0.1x |
| Debt / equity | 0.4x | 0.3x | 0.4x | 0.3x | 0.3x | 0.3x | β | β | β | β |
| Interest coverage | 5.3x | 5.9x | 4.4x | 4.3x | 0.8x | 8.3x | β0.2x | 2.7x | 2.6x | 3.4x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.3% | 0.4% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.5% | 0.4% |
| Quality scores | ||||||||||
| Accruals ratio | β1.4% | β0.7% | β2.1% | β1.8% | β1.0% | β0.1% | β0.8% | β0.6% | β0.8% | β0.4% |
Source: SEC EDGAR XBRL filings (CIK 0001137774). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.